Company profile
Kangdesai Medical Technology company profile
Kandesai is a personalized tumor immunotherapy developer, focusing on the development of immunotherapy platforms based on tumor neoantigens. It has independently developed 3 tumor drug pipelines based on neoantigens and innovative pipelines for liver cirrhosis with independent intellectual property rights. Help patients suppress tumor recurrence and metastasis.
Business identity
- Website
- http://www.cunde.com/
- Contact email
- [email protected]
- Phone number
- +86 028-69261055
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 51-100 employees
- Founded
- 2016-11-07
Headquarters
- Headquarters
- Chengdu, Sichuan, China
- Country code
- CN
- Continent
- Asia